Literature DB >> 28814375

Influencers of generic drug utilization: A systematic review.

Jennifer N Howard1, Ilene Harris2, Gavriella Frank3, Zippora Kiptanui4, Jingjing Qian5, Richard Hansen6.   

Abstract

INTRODUCTION: With an increase in prescription drug spending and rising drug costs there is a need to encourage the use of generic prescription drugs. However, maximizing generic drug use is not possible without the public's positive perception and meeting their informational needs about generic drugs. Thus, improving the public's confidence in, and knowledge of generic drugs on the market is critical. The objective of this systematic review is to examine and evaluate the studies focusing on the nature and extent of key factors influencing generic drug use in the United States in order to help guide policy, education and practice interventions.
MATERIALS AND METHODS: Using multiple search engines and key word screening criteria, empirical studies published in English between January 1, 2005 and December 31, 2015 were identified. A qualitative synthesis of the evidence identified domains of key factors that influenced generic drug use across studies.
RESULTS: Over 3000 citations met the key word screening criteria; 67 of these met inclusion criteria for the systematic review. Seven domains of factors that influence generic drug utilization were identified: 1) patient-related factors, 2) formulary management or cost containment, 3) healthcare policies, 4) promotional activities, 5) educational initiatives, 6) technology, and 7) physician-related factors.
CONCLUSION: Patients, physicians, pharmacists, formulary managers, and policymakers play an important role in generic drug use. Understanding the factors influencing generic drug use can help guide future policy, education, and practice interventions to increase generic drug use.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug substitution; Drugs; Generic; Health personnel attitudes; Health policy; Patient perception

Mesh:

Substances:

Year:  2017        PMID: 28814375      PMCID: PMC5910277          DOI: 10.1016/j.sapharm.2017.08.001

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  80 in total

1.  Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.

Authors:  Amy B Scott; Eric J Culley; Jerry O'Donnell
Journal:  J Manag Care Pharm       Date:  2007-06

2.  Changes in Medicaid prescription volume and use in the wake of Medicare Part D implementation.

Authors:  Brian K Bruen; Laura M Miller
Journal:  Health Aff (Millwood)       Date:  2008 Jan-Feb       Impact factor: 6.301

3.  State generic substitution laws can lower drug outlays under Medicaid.

Authors:  William H Shrank; Niteesh K Choudhry; Jessica Agnew-Blais; Alex D Federman; Joshua N Liberman; Jun Liu; Aaron S Kesselheim; M Alan Brookhart; Michael A Fischer
Journal:  Health Aff (Millwood)       Date:  2010-07       Impact factor: 6.301

4.  The effects of the coverage gap on drug spending: a closer look at Medicare Part D.

Authors:  Yuting Zhang; Julie Marie Donohue; Joseph P Newhouse; Judith R Lave
Journal:  Health Aff (Millwood)       Date:  2009-02-03       Impact factor: 6.301

5.  Patients' perceptions of generic medications.

Authors:  William H Shrank; Emily R Cox; Michael A Fischer; Jyotsna Mehta; Niteesh K Choudhry
Journal:  Health Aff (Millwood)       Date:  2009 Mar-Apr       Impact factor: 6.301

6.  Beliefs about generic drugs among elderly adults in hospital-based primary care practices.

Authors:  Alice Iosifescu; Ethan A Halm; Thomas McGinn; Albert L Siu; Alex D Federman
Journal:  Patient Educ Couns       Date:  2008-11

7.  Impact of medicare part D plan features on use of generic drugs.

Authors:  Yan Tang; Walid F Gellad; Aiju Men; Julie M Donohue
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

8.  Generic immunosuppression: deciphering the message our patients are receiving.

Authors:  Amanda L Hulbert; Nicole A Pilch; David J Taber; Kenneth D Chavin; Prabhakar K Baliga
Journal:  Ann Pharmacother       Date:  2012-05-08       Impact factor: 3.154

9.  The impact of the Medicare Part D prescription benefit on generic drug use.

Authors:  James X Zhang; Wesley Yin; Shawn X Sun; G Caleb Alexander
Journal:  J Gen Intern Med       Date:  2008-07-26       Impact factor: 5.128

10.  Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study.

Authors:  Jette Rathe; Morten Andersen; Dorte Ejg Jarbøl; René dePont Christensen; Jesper Hallas; Jens Søndergaard
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

View more
  11 in total

1.  Attitude and Purchase Intention to Generic Drugs.

Authors:  Ricardo Arcaro; Cássia Rita Pereira da Veiga; Wesley Vieira da Silva; Claudimar Pereira da Veiga
Journal:  Int J Environ Res Public Health       Date:  2021-04-26       Impact factor: 3.390

2.  The adoption of generic drugs by a hospital: effects on drug dispensation among community pharmacies.

Authors:  Tomoya Tachi; Kosuke Saito; Hiroki Esaki; Ikuto Sugita; Aki Yoshida; Yuta Kanematsu; Yoshihiro Noguchi; Michi Umeda; Masahiro Yasuda; Takashi Mizui; Teruo Tsuchiya; Chitoshi Goto; Hitomi Teramachi
Journal:  J Pharm Health Care Sci       Date:  2018-03-14

3.  Drug switching in the Netherlands: a cohort study of 20 active substances.

Authors:  Pieter J Glerum; Marc Maliepaard; Vincent de Valk; David M Burger; Kees Neef
Journal:  BMC Health Serv Res       Date:  2020-07-13       Impact factor: 2.655

4.  Use of generic medicines in Latvia: awareness, opinions and experiences of the population.

Authors:  Ieva Salmane Kulikovska; Elita Poplavska; Marija Ceha; Signe Mezinska
Journal:  J Pharm Policy Pract       Date:  2019-01-06

5.  Swedish patients' trust in the bioequivalence of interchangeable generics. What factors are important for low trust?

Authors:  Erika Olsson; Karin Svensberg; Helle Wallach-Kildemoes; Emma Carlsson; Caroline Hällkvist; Susanne Kaae; Sofia Kälvemark Sporrong
Journal:  Pharm Pract (Granada)       Date:  2018-12-14

6.  The impact of Medicare part D prescription drug benefit program on generic drug prescription: A study in long-term care facilities.

Authors:  Changmi Jung; Rema Padman; Shamena Anwar
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program.

Authors:  Mariana P Socal; Ge Bai; Gerard F Anderson
Journal:  JAMA Netw Open       Date:  2021-03-01

8.  Type 2 diabetes pharmacotherapy trends in high-risk subgroups.

Authors:  Jay Bae; Dongju Liu; Chanadda Chinthammit; Zbigniew Kadziola; Kristina Boye; Kieren Mather
Journal:  Diabetes Obes Metab       Date:  2022-03-22       Impact factor: 6.408

9.  Perceptions of generic medicines and medication adherence after percutaneous coronary intervention: a prospective multicentre cohort study.

Authors:  Trond Røed Pettersen; Jan Schjøtt; Heather G Allore; Bjørn Bendz; Britt Borregaard; Bengt Fridlund; Alf Inge Larsen; Jan Erik Nordrehaug; Svein Rotevatn; Tore Wentzel-Larsen; Tone Merete Norekvål
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

10.  Representative sample survey on factors determining the Czech physicians' awareness of generic drugs and substitution.

Authors:  J Maly; E Zimcikova; J Babica; A A Kubena; J Kostriba; K Mala-Ladova
Journal:  BMC Health Serv Res       Date:  2019-10-30       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.